These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2026569)

  • 1. Chemoprevention of cancer.
    Garewal HS; Meyskens FL
    Hematol Oncol Clin North Am; 1991 Feb; 5(1):69-77. PubMed ID: 2026569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based approach to cancer prevention clinical trials.
    Greenwald P; McDonald SS; Anderson DE
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer chemoprevention.
    Hong WK; Lippman SM
    J Natl Cancer Inst Monogr; 1995; (17):49-53. PubMed ID: 8573453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer prevention: recent progress and future opportunities.
    Weinstein IB
    Cancer Res; 1991 Sep; 51(18 Suppl):5080s-5085s. PubMed ID: 1884384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and strategies for chemoprevention of cancer in humans.
    Bertram JS; Kolonel LN; Meyskens FL
    Cancer Res; 1987 Jun; 47(11):3012-31. PubMed ID: 3105872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer chemoprevention: an integrated approach.
    Lippman SM; Spitz MR
    J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
    Herberman RB; Pearce HL; Lippman SM; Pyenson BS; Alberts DS
    Cancer Res; 2006 Dec; 66(24):11540-9. PubMed ID: 17158189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of oral cancer: the need for effective biological monitoring.
    Pillai MR; Ravi D; Nair MK
    Singapore Dent J; 1997 Aug; 22(1):6-12. PubMed ID: 10597170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.